Trial intelligence / Profile preview

Effect of Prophylactic Fibrinogen Concentrate in Scoliosis Surgery (EFISS)

2021-005493-25Phase 4Completed

Sponsor
Fakultní nemocnice Brno
Start
Feb 2022
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

Phase 4, randomised trial of Fibrinogen human in scoliosis (2 arms), sponsored by Fakultní nemocnice Brno. Started Feb 2022; status: completed.

02

Drugs

Fibrinogen human
03

Conditions

scoliosis

Beyond the preview

Go deeper on 2021-005493-25.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2021-005493-25.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call